PTGX

Protagonist Therapeutics (PTGX) Investor Questions

Review Protagonist Therapeutics (PTGX) faq with server-rendered company data, supporting context and links to related investor research.

Company
Protagonist Therapeutics
Sector
Healthcare
Industry
Biotechnology
Overall BTI score
75
Annual revenue
$46.02M
Annual net income
$-130.15M
Annual free cash flow
$56.08M

Protagonist Therapeutics (PTGX) Investor Questions research

Protagonist Therapeutics trades under the ticker PTGX. The company is classified in the Healthcare sector and the Biotechnology industry.

Investors commonly review PTGX through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. The linked research sections provide a separate crawlable page for each data-rich topic.